| Financial Year |
March 31 2023 |
| Monetary Funds |
1,407,241,970.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
152,026,188.33 |
| Accounts Receivable |
338,240,687.41 |
| Advances to Suppliers |
122,604,644.84 |
| Other Receivables |
195,197,160.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
425,208,250.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,811,154.78 |
| Total Current Assets |
2,692,850,567.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,637,735.52 |
| Investment Properties |
-- |
| Fixed Assetes |
1,089,372,828.93 |
| Under-construction Projects |
219,945,598.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
219,822,745.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
97,435.68 |
| Deferred Income Tax Assets |
22,726,952.79 |
| Other Non-Current Assets |
264,418,747.78 |
| Sub-Total of Non-Current Assets |
1,831,275,273.67 |
| Total Assets |
4,524,125,841.17 |
| Short-Term Loans |
92,800,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
87,500,000.00 |
| Accounts Payable |
155,654,095.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,473,447.37 |
| Taxes Payable |
55,953,066.31 |
| Interest Payable |
2,178,517.00 |
| Dividend Payable |
420,400.89 |
| Other payables |
59,756,979.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,500,000.00 |
| Other Current Liabilities |
124,282,440.29 |
| Sub-Total of Current Liabilities |
690,080,920.95 |
| Long-term Loans |
561,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
402,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
112,342.24 |
| Other Non-Current Liabilities |
23,929,134.04 |
| Sub-Total of Non-Current Liabilities |
868,285,936.73 |
| Total Liabilities |
1,558,366,857.68 |
| Paid-In Capital(Or Share Stock) |
558,742,416.00 |
| Capital Surplus |
1,195,551,098.18 |
| Surplus Reserve |
112,032,010.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
941,248,120.50 |
| Minority Stockholder's Interest |
146,819,176.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,818,939,806.73 |
| Owner's Equity（Stockholder's Equity） |
2,965,758,983.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,524,125,841.17 |
